# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. "
Stifel analyst Jonathan Block maintains Zoetis (NYSE:ZTS) with a Buy and maintains $200 price target.
Piper Sandler analyst David Westenberg maintains Zoetis (NYSE:ZTS) with a Overweight and raises the price target from $195 t...
BTIG analyst Mark Massaro maintains Zoetis (NYSE:ZTS) with a Buy and raises the price target from $220 to $225.